IRGM and squamous cell lung carcinoma: Yuan et al., have recently found that NSD3-T1232A could drive squamous cell lung cancer progression by robustly increasing H3K36m2 and transcriptional activation of several key oncogenic genes, including Prkaa2, Myc, and Irgm1 [19].